Tag: biomedical
-
Risks of E-Cigarette Use, Ingredients Highlighted
Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes.
-
University, Drug Maker Partner on Suicide Genetics
Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks.
-
NIH Funds Heart Tissue Regeneration Tests in Pigs
An experimental drug to help grow new heart tissue after a heart attack is advancing to tests in pigs, with help from National Institutes of Health.
-
Wearable-Implant Diagnostics Device in Development
A university engineering lab is developing a device combining a sensor chip implanted under the skin and wrist band to diagnose serious diseases and transmit the data.
-
MIT, IBM Open Artificial Intelligence Lab
Massachusetts Institute of Technology and IBM are establishing a joint lab to advance the state of knowledge and business impact of artificial intelligence.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.
-
Phone App Found to Measure Heart Health Metrics
A medical engineering team designed a smartphone app that in a clinical study shows it can measure key factors in heart health as accurately as MRI scans.
-
Engineered T-Cell Trials Stopped after Patient Death
The Food and Drug Administration stopped two clinical trials testing genetically engineered T-cells from the immune system to treat leukemia, after a participant in one trial died.
-
Trial Underway Testing Alzheimer’s-Schizophrenia Drug
A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease.
-
Simple Cell Programming Designed for Gene Therapies
A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia.